La plateforme d'IA génomique d'Advitam a été présentée dans les principales publications mondiales.
Vu dans
Health & Science
Advitam leads the charge with Evo2-powered diagnostics, bringing single-nucleotide precision to clinical practice. The platform, built on NVIDIA BioNeMo infrastructure, represents a breakthrough in accessible genomic analysis.
Technology
From a cafe in Marrakech to the frontlines of precision medicine — Advitam is making NVIDIA-powered genomic AI accessible to healthcare professionals worldwide, with 90% accuracy on BRCA1 predictions.
Wissenschaft
Advitam bringt das Evo2-Modell des Arc Institute in die klinische Praxis. Mit NVIDIA BioNeMo können Ärzte genetische Sequenzen von bis zu einer Million Nukleotiden in einem Durchgang analysieren.
Présentation de l'entreprise, résumé technologique et biographies des fondateurs au format PDF.
Founded
2025
Headquarters
Marrakech, Morocco
Technology
Evo2 + NVIDIA BioNeMo
Focus
Genomic AI for Healthcare
Patrick Chassany
Founder — Concept
Aldric Laure
Founder — CEO
Media inquiries: press@advitam.ai